AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionOxbow Advisors, LLC
Latest Disclosed Ownership23,474 shares
Latest Disclosed Value $ 5,105,345
Oxbow Advisors, LLC reports 1.52% increase in ownership of 4AB / AbbVie Inc.

On April 27, 2026 - Oxbow Advisors, LLC filed a 13F-HR form disclosing ownership of 23,474 shares of AbbVie Inc. (BG:4AB) valued at $5,105,345 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 23,122 shares of AbbVie Inc.. This represents a change in shares of 1.52% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F ABBVIE COM 00287Y109 23,474 352 1.52 5,105 -3.37 0.4339
2026-02-04 2025-12-31 13F ABBVIE COM 00287Y109 23,122 -200 -0.86 5,283 -2.15 0.4648
2025-10-31 2025-09-30 13F ABBVIE COM 00287Y109 23,322 335 1.46 5,400 26.56 0.5015
2025-07-29 2025-06-30 13F ABBVIE COM 00287Y109 22,987 15,967 227.45 4,267 190.20 0.4663
2025-05-01 2025-03-31 13F ABBVIE COM 00287Y109 7,020 -100 -1.40 1,471 16.21 0.1554
2025-02-03 2024-12-31 13F ABBVIE COM 00287Y109 7,120 88 1.25 1,265 -8.86 0.1489
2024-11-01 2024-09-30 13F ABBVIE COM 00287Y109 7,032 -327 -4.44 1,389 9.98 0.1378
2024-08-06 2024-06-30 13F ABBVIE COM 00287Y109 7,359 0 0.00 1,262 -5.82 0.1481
2024-05-06 2024-03-31 13F ABBVIE COM 00287Y109 7,359 294 4.16 1,340 22.49 0.1840
2024-02-08 2023-12-31 13F ABBVIE COM 00287Y109 7,065 -517 -6.82 1,095 -3.19 0.1661
2023-11-14 2023-09-30 13F ABBVIE COM 00287Y109 7,582 1,212 19.03 1,130 31.70 0.1779
2023-08-04 2023-06-30 13F ABBVIE COM 00287Y109 6,370 -90 -1.39 858 -16.62 0.1348
2023-04-26 2023-03-31 13F ABBVIE COM 00287Y109 6,460 -51 -0.78 1,030 -2.19 0.1841
2023-02-01 2022-12-31 13F ABBVIE COM 00287Y109 6,511 -104 -1.57 1,052 18.47 0.1983
2022-11-03 2022-09-30 13F Abbvie COM 00287Y109 6,615 213 3.33 888 -9.48 0.1395
2022-08-10 2022-06-30 13F Abbvie COM 00287Y109 6,402 181 2.91 981 -2.68 0.1393
2022-05-09 2022-03-31 13F Abbvie COM 00287Y109 6,221 -2,679 -30.10 1,008 -16.35 0.1013
2022-02-09 2021-12-31 13F Abbvie COM 00287Y109 8,900 -70 -0.78 1,205 24.48 0.1154
2021-11-10 2021-09-30 13F Abbvie COM 00287Y109 8,970 -18 -0.20 968 -4.35 0.0984
2021-08-04 2021-06-30 13F Abbvie COM 00287Y109 8,988 18 0.20 1,012 4.22 0.1052
2021-05-11 2021-03-31 13F Abbvie COM 00287Y109 8,970 -2,165 -19.44 971 -18.61 0.1182
2021-02-02 2020-12-31 13F Abbvie COM 00287Y109 11,135 375 3.49 1,193 26.65 0.1527
2020-11-06 2020-09-30 13F Abbvie COM 00287Y109 10,760 1,190 12.43 942 0.21 0.1195
2020-08-12 2020-06-30 13F Abbvie COM 00287Y109 9,570 -1,277 -11.77 940 13.80 0.1368
2020-05-06 2020-03-31 13F Abbvie COM 00287Y109 10,847 -45 -0.41 826 -14.32 0.1389
2020-02-06 2019-12-31 13F Abbvie COM 00287Y109 10,892 -2,130 -16.36 964 -2.23 0.1114
2019-10-31 2019-09-30 13F Abbvie COM 00287Y109 13,022 -97,337 -88.20 986 -87.71 0.1310
2019-08-07 2019-06-30 13F Abbvie COM 00287Y109 110,359 29,771 36.94 8,025 23.56 0.9664
2019-05-01 2019-03-31 13F Abbvie COM 00287Y109 80,588 -2,742 -3.29 6,495 -15.45 0.7900
2019-02-12 2018-12-31 13F Abbvie COM 00287Y109 83,330 14,004 20.20 7,682 17.16 1.0266
2018-11-06 2018-09-30 13F Abbvie COM 00287Y109 69,326 3,090 4.67 6,557 6.84 0.7906
2018-08-09 2018-06-30 13F Abbvie COM 00287Y109 66,236 -2,402 -3.50 6,137 -5.54 0.7811
2018-04-30 2018-03-31 13F Abbvie COM 00287Y109 68,638 -10,433 -13.19 6,497 -15.04 1.3243
2018-01-30 2017-12-31 13F Abbvie COM 00287Y109 79,071 -1,742 -2.16 7,647 6.49 1.4320
2017-10-23 2017-09-30 13F ABBVIE COM 00287Y109 80,813 -6,273 -7.20 7,181 13.71 1.3670
2017-07-21 2017-06-30 13F ABBVIE COM 00287Y109 87,086 -410 -0.47 6,315 10.77 1.1159
2017-04-28 2017-03-31 13F ABBVIE COM 00287Y109 87,496 447 0.51 5,701 4.57 0.9261
2017-01-26 2016-12-31 13F ABBVIE COM 00287Y109 87,049 -1,898 -2.13 5,452 -2.89 0.6810
2016-10-31 2016-09-30 13F ABBVIE COM 00287Y109 88,947 -1,168 -1.30 5,614 0.61 0.7707
2016-08-02 2016-06-30 13F ABBVIE COM 00287Y109 90,115 -1,143 -1.25 5,580 7.00 0.7991
2016-05-02 2016-03-31 13F ABBVIE COM 00287Y109 91,258 -1,568 -1.69 5,215 -5.18 0.7385
2016-02-01 2015-12-31 13F ABBVIE COM 00287Y109 92,826 84,967 1,081.14 5,500 1,188.06 0.6869
2015-11-03 2015-09-30 13F/A-1 ABBVIE COM 00287Y109 7,859 662 9.20 427 -11.78 0.0703
2015-11-03 2015-09-30 13F ABBVIE COM 00287Y109 7,318 398
2015-08-11 2015-06-30 13F ABBVIE COM 00287Y109 7,197 209 2.99 484 18.34 0.0625
2015-04-23 2015-03-31 13F ABBVIE COM 00287Y109 6,988 2 0.03 409 -10.50 0.0608
2015-01-21 2014-12-31 13F ABBVIE COM 00287Y109 6,986 -399 -5.40 457 7.03 0.0639
2014-10-21 2014-09-30 13F/A-1 ABBVIE COM 00287Y109 7,385 200 2.78 427 5.17 0.0604
2014-10-20 2014-09-30 13F ABBVIE COM 00287Y109 7,185 406
2014-07-18 2014-06-30 13F ABBVIE COM 00287Y109 7,185 0 0.00 406 10.03 0.0539
2014-04-21 2014-03-31 13F ABBVIE COM 00287Y109 7,185 0 0.00 369 -2.64 0.0547
2014-01-21 2013-12-31 13F ABBVIE COM 00287Y109 7,185 0 0.00 379 18.07 0.0534
2013-10-24 2013-09-30 13F ABBVIE COM 00287Y109 7,185 0 0.00 321 8.08 0.0512
2013-07-30 2013-06-30 13F ABBVIE COM 00287Y109 7,185 7,185 297 0.0521
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.